What is Xarelto?
Xarelto (rivaroxaban) is one of the newest anticoagulant prescription medications manufactured by Bayer and marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals, Inc. Xarelto is an oral medication prescribed to prevent blood clots from forming due to atrial fibrillation or hip or knee replacement surgery and treat blood clots in patients with deep vein thrombosis or pulmonary embolus.
For years, Warfarin was the standard anticoagulant, but Warfarin requires changes in diet and lifestyle, regular checkups and has a risk of brain hemorrhage. Xarelto was developed and marketed as a safer and more convenient alternative because it only has to be taken once a day and does not require frequent visits to the doctor.
What Are the Side Effects of Xarelto
Xarelto may cause irreversible internal bleeding that can lead to hospitalization and even death. While the risk of bleeding exists with similar medications, Xarelto is more dangerous because it does not have an antidote. For example, if a patient on Warfarin suffers a bleeding event, doctors can use a vitamin K antidote to stop the bleeding. Xarelto does not have an antidote so doctors cannot stop the bleeding. As a result, patients who suffer bleeding can end up hospitalized and the bleed may be fatal.